UBS upgraded Altria Group (NYSE: MO) to Neutral from Sell, saying stepped-up enforcement against illicit e-cigarette imports, ...

Investing.com -- Regeneron Pharmaceuticals (NASDAQ: REGN) stock rose 2.8% after the U.S. Food and Drug Administration granted accelerated approval for the company’s blood cancer therapy Lynozyfic.